On June 30th-July 1, 2022 the research team at Epicentre in Mbarara, Uganda held a two-day workshop about their recent work to address gaps in tuberculosis diagnostics and therapeutics in low-income countries. Sessions included:
• Landscape of TB disease in Uganda: research gaps
• New diagnostic tools and algorithms in adults
• New diagnostic tools and algorithms in children
• Approaches to increasing pediatric TB detection and reducing disease burden
• TB chemotherapeutics
• Perspectives and challenges in TB
To catch up on the presentations, you can view the abstracts through the link below.
The endTB project aims to find shorter, less toxic and more effective treatments for ‘multidrug-resistant TB’ (MDR-TB) through:
Covering 18 countries, the project is a partnership between Partners In Health, Médecins Sans Frontières, Interactive Research & Development and financial partners Unitaid and the Transformational Investment Capacity (TIC) of MSF. This collection contains the final and intermediate results of the studies, advocacy reports, and study presentations. For more information about the endTB project, visit https://endtb.org/.